These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 4596741)

  • 21. In vitro and in vivo antibacterial activities of CS-807, a new oral cephalosporin.
    Utsui Y; Inoue M; Mitsuhashi S
    Antimicrob Agents Chemother; 1987 Jul; 31(7):1085-92. PubMed ID: 3310868
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and laboratory evaluation of cefanone, a new cephalosporin antibiotic.
    Noriega ER; Rubinstein E; Simberkoff MS; Rahal JJ
    Am J Med Sci; 1974 Jun; 267(6):353-7. PubMed ID: 4601711
    [No Abstract]   [Full Text] [Related]  

  • 23. Microbiological properties of a new cephalosporin, BL-S 339: 7-(phenylacetimidoyl-aminoacetamido)-3-(2-methyl-1,3,4-thiadiazol-5-ylthiomethyl)ceph-3-em-4-carboxylic acid.
    Misiek M; Pursiano TA; Leitner F; Price KE
    Antimicrob Agents Chemother; 1973 Jan; 3(1):40-8. PubMed ID: 4790575
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Phlebitis associated with cephalosporins: cephapirin versus cephalothin.
    Inagaki J; Bodey GP
    Curr Ther Res Clin Exp; 1973 Feb; 15(2):37-43. PubMed ID: 4632504
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro antimicrobial activity and human pharmacology of cephalexin, a new orally absorbed cephalosporin C antibiotic.
    Thornhill TS; Levison ME; Johnson WD; Kaye D
    Appl Microbiol; 1969 Mar; 17(3):457-61. PubMed ID: 4388601
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phlebitis associated with the intravenous use of cephapirin and cephalothin in the combination therapy of antibiotics.
    Meguro S; Kuraishi Y; Kobayashi T; Chinen T; Ikeda K; Nagata T; Ichiba K; Abe M
    Jpn J Antibiot; 1980 Nov; 33(11):1163-5. PubMed ID: 7241794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cefotaxime, cephalothin, and cephapirin: antimicrobial activity and synergy studies of cephalosporins with significant in vivo desacetyl metabolite concentrations.
    Jones RN; Packer RR
    Diagn Microbiol Infect Dis; 1984 Jan; 2(1):65-8. PubMed ID: 6100364
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity and pharmacokinetics in patients of cefamandole, a new cephalsoporin antibiotic.
    Shemonsky NK; Carrizosa J; Levison ME
    Antimicrob Agents Chemother; 1975 Dec; 8(6):679-83. PubMed ID: 1211920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Laboratory evaluation of FR10024 a new cephalosporin derivative.
    Nishida M; Murakawa T; Kamimura T; Okada N; Fukada S
    Antimicrob Agents Chemother; 1977 Jan; 11(1):51-63. PubMed ID: 836014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relative incidence of phlebitis caused by continuous intravenous infusion of cephapirin and cephalothin.
    Lane AZ; Taggart JG; Iles RL
    Antimicrob Agents Chemother; 1972 Sep; 2(3):234-5. PubMed ID: 4790563
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro studies of cefamandole.
    Bodey GP; Weaver S
    Antimicrob Agents Chemother; 1976 Mar; 9(3):452-7. PubMed ID: 769679
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bactericidal killing activities of cefepime, ceftazidime, cefotaxime, and ceftriaxone against Staphylococcus aureus and beta-lactamase-producing strains of Enterobacter aerogenes and Klebsiella pneumoniae in an in vitro infection model.
    Palmer SM; Kang SL; Cappelletty DM; Rybak MJ
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1764-71. PubMed ID: 7486916
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the in vitro activity of a new cephalosporin, cefuroxime, and cephalothin against 810 clinical isolates.
    Skar AG; Midtvedt T; Dahl O
    NIPH Ann; 1979 Dec; 2(2):31-40. PubMed ID: 398460
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftezole, a new cephalosporin C derivative I. In vitro and in vivo antimicrobial activity.
    Noto T; Nehashi T; Endo H; Saito M; Matsubara S
    J Antibiot (Tokyo); 1976 Oct; 29(10):1058-70. PubMed ID: 994325
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cefazolin in the treatment of bacterial pneumonia.
    Turck M; Clark RA; Beaty HN; Holmes KK; Karney WW; Reller LB
    J Infect Dis; 1973 Oct; 128():Suppl:S382-5. PubMed ID: 4147579
    [No Abstract]   [Full Text] [Related]  

  • 36. SCE-963, a new broad-spectrum cephalosporin: in vitro and in vivo antibacterial activities.
    Tsuchiya K; Kida M; Kondo M; Ono H; Takeuchi M; Nishi T
    Antimicrob Agents Chemother; 1978 Oct; 14(4):557-68. PubMed ID: 718154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of antibacterial activities of cephalosporin antibiotics: cefazolin, cephaloridine, cephalothin, and cephalexin.
    Hsieh WC; Ho SW
    Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi; 1975 Mar; 8(1):1-11. PubMed ID: 1097210
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of antibacterial activity of a new cephalosporin, ceftizoxime (FK 749) with other cephalosporin antibiotics.
    Nishida M; Kamimura T; Okada N; Matsumoto Y; Mine Y; Murakawa T; Goto S; Kuwahara S
    J Antibiot (Tokyo); 1979 Dec; 32(12):1319-27. PubMed ID: 317284
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vitro and in vivo microbiological evaluation of Cephapirin, a new antibiotic.
    Renzini G; Ravagnan G; Oliva B
    Chemotherapy; 1975; 21(5):289-96. PubMed ID: 1098870
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical studies of cefazolin and comparison with other cephalosporins.
    Madhavan T; Quinn EL; Freimer E; Fisher EJ; Cox F; Burch K; Pohlod D
    Antimicrob Agents Chemother; 1973 Nov; 4(5):525-31. PubMed ID: 4791486
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.